Co-Diagnostics: Funding, Investors & Team (Sep 2026)
Co-Diagnostics is a company specializing in molecular diagnostics, offering an advanced technology for developing, producing, and promoting diagnostic products. This technology involves the utilization of nucleic acid molecules (DNA or RNA) for detecting and analyzing various tests. Additionally, the company uses its unique technology to create customized tests for identifying genetic markers in industries beyond infectious diseases and grants licenses to specific clients for utilizing those tests.
Co-Diagnostics has raised $3.0M across 2 funding rounds on record, the most recent an undisclosed round of $3.0M announced in May 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Co-Diagnostics Company Profile and Key Stats
Latest funding round on record: May 2026.
Co-Diagnostics Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
Co-Diagnostics announced an undisclosed round in Jul 2023; the amount was not disclosed.
2.8 years later, an undisclosed round of $3.0M was announced in May 2026.
Co-Diagnostics Founders and Leadership Team
No contact details are on record for this team yet.
Co-Diagnostics Funding Compared to Other Biotechnology Startups
Co-Diagnostics' latest round of $3.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Co-Diagnostics in Biotechnology and Salt Lake City
Companies Similar to Co-Diagnostics
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Co-Diagnostics Funding FAQs
What does Co-Diagnostics do?
Co-Diagnostics is a company specializing in molecular diagnostics, offering an advanced technology for developing, producing, and promoting diagnostic products. This technology involves the utilization of nucleic acid molecules (DNA or RNA) for detecting and analyzing various tests. Additionally, the company uses its unique technology to create customized tests for identifying genetic markers in industries beyond infectious diseases and grants licenses to specific clients for utilizing those tests.
How much funding has Co-Diagnostics raised?
Co-Diagnostics has raised $3.0M across 2 rounds on record. The most recent is an undisclosed round of $3.0M announced in May 2026.
When did Co-Diagnostics last raise funding?
Co-Diagnostics' most recent funding round on record is an undisclosed round of $3.0M, announced in May 2026.
Who founded Co-Diagnostics?
FundedIQ lists Dwight Egan (Founder) at Co-Diagnostics.
Where is Co-Diagnostics headquartered?
Co-Diagnostics is based in Salt Lake City, Utah, United States.
How many employees does Co-Diagnostics have?
Co-Diagnostics is in the 101-250 employee band.
How does Co-Diagnostics' funding compare to other Biotechnology startups?
Co-Diagnostics' latest round of $3.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Co-Diagnostics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Co-Diagnostics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.